
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group reported total revenue of $1,649 million, reflecting an approximate 8.1% year-over-year increase, primarily driven by strong demand in its Market Data segment, which grew around 14.5% year-over-year. The company has demonstrated robust free cash flow generation, allowing it to consistently increase quarterly dividend payments for over 14 consecutive years, indicating a solid commitment to returning value to shareholders. Additionally, CME has successfully achieved a compound annual growth rate of over 7% in average daily volume from FY16 through FY24, supported by heightened customer demand and ongoing product innovation, further enhancing the company's revenue potential.
Bears say
CME Group faces a negative outlook primarily due to anticipated declines in interest rate futures trading volume resulting from an impending rate-cutting cycle, alongside increased competition from alternative exchanges. Projections indicate a revenue growth of approximately 5.4% year-over-year to around $6,872 million, which falls short of consensus expectations of 6.0% growth, exacerbating concerns over pricing pressures and limited margin improvements. Additionally, regulatory risks, including potential increases in margin requirements and trading limitations, pose further threats to trading volume and overall company performance.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares